<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:hpo ids='HP_0001513'>obesity</z:hpo> epidemic has resulted in more young people having high-risk profiles for the development of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Screening to promote earlier diagnosis and treatment of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> is of significant importance, as untreated disease leads to metabolic, microvascular, and macrovascular complications </plain></SENT>
<SENT sid="2" pm="."><plain>However, the choice of screening methodology in adolescents is controversial, and implementation of screening protocols is not uniform </plain></SENT>
<SENT sid="3" pm="."><plain>Expert panels have recommended the use of glycated <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> (A1c) for the diagnosis of <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetes</z:e> and <z:mp ids='MP_0002055'>diabetes</z:mp>, based on the facts that the A1c assay has technical advantages and correlates well with the risk of microvascular <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>However, these recommendations are based strictly on data from adult studies and lack any input based on pediatric research </plain></SENT>
<SENT sid="5" pm="."><plain>The pediatric research that has been published on the topic indicates that using adult cutoff points for A1c values to predict <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetes</z:e> or <z:mp ids='MP_0002055'>diabetes</z:mp> significantly underestimates the prevalence of these conditions in the pediatric and adolescent population </plain></SENT>
<SENT sid="6" pm="."><plain>Therefore, we call for further investigation of the role of A1c for the diagnosis of <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetes</z:e> and <z:mp ids='MP_0002055'>diabetes</z:mp> in adolescents before its adoption as a principal diagnostic method in pediatric populations </plain></SENT>
<SENT sid="7" pm="."><plain>We contend that a more comprehensive <z:mp ids='MP_0002055'>diabetes</z:mp> evaluation, along with A1c, remains necessary for screening adolescents at high risk for <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetes</z:e> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain>Collaborative multicentered studies of <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetes</z:e> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in the <z:mp ids='MP_0001261'>obese</z:mp> pediatric population are especially needed to determine the A1c cutoff points, as well as other diagnostic measures, that best predict <z:mp ids='MP_0002055'>diabetes</z:mp>-related comorbid conditions later in life </plain></SENT>
</text></document>